Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.

about

Targeting and isolation of cancer cells using micro/nanomotors.Microfluidic approaches for cell-based molecular diagnosis Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring

P2860

Q45983589-86CF45FB-332A-4D01-BA53-54C59CD5D302 Q57074747-3374D3CA-0541-4D4A-8B1B-8E246729D327 Q58704141-F7A47A03-A87C-48E2-AB8B-1BD050774E01

P2860

Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.

Item

http://www.wikidata.org/entity/Q38963129

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Promise and limits of the Cell ...... cs in circulating tumor cells.

@en

type

Item

label

Promise and limits of the Cell ...... cs in circulating tumor cells.

@en

prefLabel

Promise and limits of the Cell ...... cs in circulating tumor cells.

@en

P1476

Promise and limits of the Cell ...... cs in circulating tumor cells.

@en

P2093

Alice P Chen

http://www.w3.org/2001/XMLSchema#string

Lihua Wang

http://www.w3.org/2001/XMLSchema#string

Priya Balasubramanian

http://www.w3.org/2001/XMLSchema#string

Robert J Kinders

http://www.w3.org/2001/XMLSchema#string

Shivaani Kummar

http://www.w3.org/2001/XMLSchema#string

Yvonne A Evrard

http://www.w3.org/2001/XMLSchema#string

P2860

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.

A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis

Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells

Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate

Portable filter-based microdevice for detection and characterization of circulating tumor cells

Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity.

P304

464-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.SEMINONCOL.2016.06.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27663478

http://www.w3.org/2001/XMLSchema#string

P932

5074690

http://www.w3.org/2001/XMLSchema#string

Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.

about

P2860

P2860

Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932